fbpx

Patent Insights

Patent Insights

Patent Filings Roundup: Medtronic Hit with Seven IPRs, Huawei Fields Multiple District Court Complaints

PTAB (31 new filings) Case Number Action Owner Petitioner Patent IPR2020-00687 Filed Parus Holdings Inc. Apple Inc. 9451084 IPR2020-00686 Filed Parus Holdings Inc. Apple Inc. 7076431 IPR2020-00715 Filed Medtronic, Inc. Axonics Modulation Technologies, Inc. 8036756 IPR2020-00714 Filed Medtronic, Inc. Axonics Modulation Technologies, Inc. 9463324 IPR2020-00681 Filed Targeted Radio LLC [Acacia] Unified Patents, LLC 8948684 IPR2020-00718 …

Patent Filings Roundup: Medtronic Hit with Seven IPRs, Huawei Fields Multiple District Court Complaints Read More »

WIPO Contributes Millions of Searchable Chemical Formulas to Database at U.S. National Institutes of Health

March 25, 2020 Discovering and developing treatments in order to alleviate suffering, bend the mortality curve and improve quality of life is a long journey. It comprises many innovative stages: in short, it starts with the understanding of the process behind a disease, followed by the identification of a molecule or compound and then by …

WIPO Contributes Millions of Searchable Chemical Formulas to Database at U.S. National Institutes of Health Read More »

Sanofi Decision Presents Opportunities to Clear the Patent Thicket for Generic Pharmaceuticals

“The Sanofi decision behooves drug sponsor, generic manufacturers, and drug purchasers alike to examine the Orange Book listings for potentially improperly listed patents.” The U.S. Court of Appeals for the First Circuit has made brand companies think twice about creating patent thickets in the Orange Book by resuscitating an antitrust suit against Sanofi by direct …

Sanofi Decision Presents Opportunities to Clear the Patent Thicket for Generic Pharmaceuticals Read More »

Everything Depends on Coronavirus R&D Partnerships—Don’t Let the Critics Wreck Them

“When we do come up with a vaccine (or more than one) the government is going to be the buyer…. And, if necessary, the government has the power to seize business assets (including inventions) to allow it to deal with a national emergency first and worry about fair compensation later. So, you’ll spend your time …

Everything Depends on Coronavirus R&D Partnerships—Don’t Let the Critics Wreck Them Read More »

The IP Bar Weighs in on CAFC Denial of Arthrex Rehearing

Yesterday, the U.S. Court of Appeals for the Federal Circuit denied rehearing en banc in Arthrex v. Smith & Nephew. Five of the 12 Federal Circuit judges wrote separately to explain their reasons for denying, or dissenting from denial on, rehearing. IPWatchdog Founder and CEO Gene Quinn said the order reveals a chaotic and disorganized …

The IP Bar Weighs in on CAFC Denial of Arthrex Rehearing Read More »

YouTube
LinkedIn
Share